Professional Publications

Cmejla, R.; Blafkova, J.; Stopka, T.; Zavadil, J.; Pospisilova, D.; Mihal, V.; Petrtylova, K.; Jelinek, J.

Ribosomal protein S19 gene mutations in patients with Diamond-Blackfan anemia and identification of ribosomal protein S19 pseudogenes

[year of publication 2006, impact factor 2.897]

Indrak, K.; Brabec, V.; Indrakova, J.; Chrobak, L.; Sakalova, A.; Jarosova, M.; Cermak, J.; Fei, Y.J.; Kutlar, F.; Gu, Y.C.

Molecular characterization of beta-thalassemia in Czechoslovakia

[year of publication 2006, impact factor 2.877]

Kuželová, K.; Grebeňová, D.; Brodská, B.

Dose-dependent effects of the caspase inhibitor Q-VD-OPh on different apoptosis-related processes

[year of publication 2011, impact factor 2.868 ]

Tachezy, R.; Hamšíková, E.; Hájek, T.; Mikyšková, I.; Šmahel, M.; Van Ranst, M.; Kaňka, J.; Havránková, A.; Rob, L.; Guttner, V.; Slavík, V.; Anton, M.; Kratochvíl, B.; Kotršová, L.; Vonka, V.

Human papillomavirus genotype spectrum in Czech women : correlation of HPV DNA presence with antibodies against HPV-16, 18 and 33 virus-like particles

[year of publication 2006, impact factor 2.867]

Petrackova, M.; Hamsikova, E.; Duskova, M.; Ptackova, P.; Klamova, H.; Humlova, Z.; Vonka, V.

Predictive value of serum cytokine levels in chronic myeloid leukemia patients

[year of publication 2016, impact factor 2.860 ]

Krejcik, Z.; Belickova, M.; Hrustincova, A.; Votavova, H.; Jonasova, A.; Cermak, J.; Dyr, J.E.; Merkerova, M.D.

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

[year of publication 2018, impact factor 2.859 ]

Cmejla, R.; Petrak, J.; Cmejlova, J.

A novel iron responsive element in the 3'UTR of human MRCKalpha

[year of publication 2007, impact factor 2.855]

Lemež, P.; Gáliková, J.; Michalová, K.; Fuchs, O.; MacWhannell, A.; Zemanová, Z.; Březinová, J.; Černá, M.; Stejskal, J.

De novo acute myeloid leukemia involving only granulocyte-macrophage line in octogenarians leucocytes over 15 × 10⁹/L exhibit a favorable response to standard-dose induction chemotherapy

[year of publication 2018, impact factor 2.850 ]

de Swart, L.; Smith, A.; MacKenzie, M.; Symeonidis, A.; Neukirchen, J.; Mikulenková, D.; Vallespi, T.; Zini, G.; Paszkowska-Kowalewska, M.; Kruger, A.; Saft, L.; Fenaux, P.; Bowen, D.; Hellström-Lindberg, E.; Čermák, J.; Stauder, R.; Tatic, A.; Holm, M.S.; Malcovati, L.; Madry, K.; Droste, J.; Blijlevens, N.; de Witte, T.; Germing, U.

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

[year of publication 2017, impact factor 2.845 ]

Chernova, M.N.; Jarolim, P.; Palek, J.; Alper, S.L.

Overexpression of AE1 Prague, but not of AE1 SAO, inhibits wild-type AE1 trafficking in Xenopus oocytes

[year of publication 2006, impact factor 2.844]

Klozar, J.; Koslabova, E.; Kratochvil, V.; Salakova, M.; Tachezy, R.

Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors

[year of publication 2012, impact factor 2.843 ]

Hilgert, I.; Franěk, F.; Štefanová, I.; Kašlík, J.; Jirka, J.; Krištofová, H.; Rossmann, P.; Souček, J.; Hořejší, V.

Therapeutic in vivo use of the A1-CD3 monoclonal antibody

[year of publication 2006, impact factor 2.841]

Brodská, B.; Holoubek, A.

Generation of reactive oxygen species during apoptosis induced by DNA-damaging agents and/or histone deacetylase inhibitors

[year of publication 2011, impact factor 2.841 ]

Motovska, Z.; Widimsky, P.; Petr, R.; Bilkova, D.; Marinov, I.; Simek, S.; Kala, P.

Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention : statin's advantage and the smoking "paradox"

[year of publication 2010, impact factor 2.826]

Brodská, H.; Malíčková, K.; Adámková, V.; Benáková, H.; Marková Šťastná, M.; Zima, T.

Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis

[year of publication 2012, impact factor 2.824 ]

Riedel, T.; Brynda, E.; Dyr, J.E.; Houska, M.

Controlled preparation of thin fibrin films immobilized at solid surfaces

[year of publication 2008, impact factor 2.816]

Filová, E.; Brynda, E.; Riedel, T.; Bačáková, L.; Chlupáč, J.; Lisá, V.; Houska, M.; Dyr, J.E.

Vascular endothelial cells on two-and three-dimensional fibrin assemblies for biomaterial coatings

[year of publication 2009, impact factor 2.816]

Messina, F.; Finocchio, A.; Akar, N.; Loutradis, A.; Michalodimitrakis, E.I.; Brdicka, R.; Jodice, C.; Novelletto, A.

Spatially explicit models to investigate geographic patterns in the distribution of forensic STRs: application to the north-eastern mediterranean

[year of publication 2016, impact factor 2.806 ]

Burda, P.; Vargova, J.; Curik, N.; Salek, C.; Papadopoulos, G.L.; Strouboulis, J.; Stopka, T.

GATA-1 inhibits PU.1 gene via DNA and histone H3K9 methylation of its distal enhancer in erythroleukemia

[year of publication 2016, impact factor 2.806 ]

Polivkova, V.; Rohon, P.; Klamova, H.; Cerna, O.; Divoka, M.; Curik, N.; Zach, J.; Novak, M.; Marinov, I.; Soverini, S.; Faber, E.; Machova Polakova, K.

Interferon-alpha revisited: individualized treatment management eased the selective pressure of tyrosine kinase inhibitors on BCR-ABL1 mutations resulting in a molecular response in high-risk CML patients

[year of publication 2016, impact factor 2.806 ]